The Cambridge-based biopharmaceutical company, founded in 2007, specializes in antibody and Fc-fusion drugs to treat auto-immune diseases, with a focus on autoimmune and inflammatory disorders. Formerly known as Centaurus Pharmaceuticals, Virdante Pharmaceuticals offers cutting-edge solutions to help patients combat these debilitating diseases.